申请人:Eisai R&D Management Co., Ltd.
公开号:US20140012011A1
公开(公告)日:2014-01-09
The present invention provides methods for preparing TLR-4 receptor agonist E6020:
and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates.